Dechra is launching a double-divisible version of Vetoryl Flavoured Tablets for dogs with Cushing's.

The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.

The new Vetoryl tablets…

Dechra is hosting ‘The three things about Cushing’s I wish I’d known sooner’, a free one-hour webinar at 7pm on Wednesday 4th June.

The company says the webinar, presented by Dechra veterinary technical advisor, Emily Casey BVM&S…

Dechra is asking vets to circulate a survey about strangles to horse-owning clients.

The survey, which takes about three minutes, will assess horse owners’ experiences of strangles and includes questions on the disease including preventative measures…

Dechra is conducting a survey of vets about otitis externa in dogs, and there's a Fortnum's hamper up for grabs.

The five-minute survey includes questions on the number of otitis externa cases seen in practice, consultation times, common compliance…

Dechra is hosting webinars for vets about strangles and equine disease prevention on Tuesday 18th February and Tuesday 25th February respectively.

The webinars will be available as live podcasts and will also be able to be viewed on demand on the Dechra…

Dechra has launched Felimazole Oral Solution 5mg/ml (thiamazole) for the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy and for the long-term treatment of feline hyperthyroidism.

The new presentation is honey-flavoured and is…

Dechra is running a series of six 30-45 minute webinars about Cushing's in dogs, starting on Tuesday 10th December.

The webinars will be presented by Professor Ian Ramsey, Ellen Behrend, Joezy Griffin, Professor Jill Maddison and Imogen Schofield.

Dechra is holding ‘Preventive strategies for strangles: linking research to action’, a free one-hour webinar to help veterinary professionals translate the latest equine strangles surveillance data and research into everyday veterinary practice, at 7:00pm…

Dechra has announced four CPD sessions it will be hosting at the London Vet Show on 14th and 15th November.

• 11:00 to 11:50 on the 14th: ‘The three things about Cushing’s I wish I’d known sooner’, presented by Emily Casey BVM&S MRCVS, veterinary technical…

Dechra has launched Furosoral for the initial treatment or maintenance therapy of conditions associated with fluid build-up in cats and dogs.

Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and…

Dechra has announced its acquisition of a Invetx, a biotech company. 

Invetx specialises in developing protein-based therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs).

Dechra says these therapies have…

Dechra has launched Lodisure, a 1mg chicken-flavoured amlodipine tablet for the treatment of feline hypertension. 

Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.

The recommended starting dose…

Dechra is hosting a one-hour canine otitis externa webinar at 7:00pm on Wednesday 31st July to share practical tips on otitis externa, how to choose the right treatments and the latest guidelines for using antibiotics responsibly.

The ‘Ear essentials…

Dechra has launched ‘They’ve got Cushing’s. You’ve got us’ marketing campaign to highlight the company’s support for Vetoryl.

Across Europe, the company has over 30 technical experts who get over 2,500 technical calls…

Dechra has launched a Cushing’s treatment and monitoring app to support owners prescribed Vetoryl for their dog.

The free app is designed to help to track changes and improvements in a dog’s health during treatment. 

The app uses questionnaires…